CRBU
CRBU
NASDAQ · Biotechnology

Caribou Biosciences Inc

$1.23
-0.01 (-0.81%)
As of Sep 28, 10:19 PM ET ·
Financial Highlights (FY 2026)
Revenue
12.41M
Net Income
-164,769,207
Gross Margin
—
Profit Margin
-1,327.4%
Rev Growth
-7.0%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin — — 33.4% 33.4%
Operating Margin -1,411.4% -1,270.3% 20.5% 22.4%
Profit Margin -1,327.4% -1,261.0% 18.2% 16.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 12.41M 13.34M 54.83M 47.58M
Gross Profit — — 18.34M 15.91M
Operating Income -175,215,583 -169,472,353 11.25M 10.65M
Net Income -164,769,207 -159,368,389 10.00M 7.87M
Gross Margin — — 33.4% 33.4%
Operating Margin -1,411.4% -1,270.3% 20.5% 22.4%
Profit Margin -1,327.4% -1,261.0% 18.2% 16.6%
Rev Growth -7.0% -7.0% -2.4% +14.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 60.52M 50.56M
Total Equity — — 94.36M 88.94M
D/E Ratio — — 0.64 0.57
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -171,147,638 -174,734,289 16.80M 15.25M
Free Cash Flow — — 9.93M 9.62M